Your browser doesn't support javascript.
loading
Tixagevimab-cilgavimab Preexposure Prophylaxis in Solid Organ Transplant Recipients Is Associated With Fewer Breakthrough SARS-CoV-2 Infections, Except During the BA.5 Period.
Al Jurdi, Ayman; Morena, Leela; Verhoeff, Rucháma; Alzahrani, Nora; Kotton, Camille N; Riella, Leonardo V.
Affiliation
  • Al Jurdi A; Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA.
  • Morena L; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Verhoeff R; Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA.
  • Alzahrani N; Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA.
  • Kotton CN; Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA.
  • Riella LV; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
Transplantation ; 107(9): e238-e240, 2023 09 01.
Article in En | MEDLINE | ID: mdl-37271875
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organ Transplantation / COVID-19 Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Transplantation Year: 2023 Document type: Article Affiliation country: Morocco Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organ Transplantation / COVID-19 Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Transplantation Year: 2023 Document type: Article Affiliation country: Morocco Country of publication: United States